The encyclopedia · Advertising & PR · Marketing decision · 2012
Lancôme said Génifique 'boosts the activity of genes' — the FDA said that makes it a drug
Sept 2012: the FDA warned Lancôme USA — claims like 'boosts the activity of genes' turned cosmetics into unapproved drugs; change the words or stop selling.
Lancôme USA · 2012-09
What happened
Lancôme USA sold its Génifique line with language borrowed from the laboratory: the products 'boost the activity of genes' and 'stimulate cell regeneration to reconstruct skin to a denser quality'. Across ten identified products, the website and labels carried gene, stem-cell and regeneration claims. The line sold on the promise of biology.
On 7 September 2012 the FDA's compliance office sent a warning letter: a product intended to affect the structure or function of the body is a drug under the Federal Food, Drug, and Cosmetic Act, and these claims made the creams drugs — unapproved new drugs, at that. The agency gave L'Oréal's Lancôme division the standard choice: change the claims, or face action up to halting sales and seizures.
The letter drew the industry's border in one sentence: cosmetics may promise to look better, drugs promise to change how the body works, and the regulator reads the claim, not the category. Génifique kept selling — with different words. In anti-aging marketing, 'gene' and 'regenerate' have read as drug claims ever since.
Why it happened
- The claims promised mechanism — gene activity, cell regeneration — which is what drugs claim, not cosmetics.
- The FDA judges the intended use from the words: the label and the website were the evidence.
- Prestige carried no exemption: the letter went to one of the biggest beauty houses in the world, publicly.
The lesson
Regulators read the claim, not the shelf it sits on: promise to change how the body works and a cream becomes an unapproved drug. Mechanism words — genes, regeneration, repair — are drug language.
Aftermath
Lancôme revised the claims and the FDA closed the letter after reviewing the corrections; Génifique remained on counters with tamer language. The case is still the industry's citation for where cosmetics end and drugs begin.
Sources
- FDA — Warning Letters Address Drug Claims Made for Products Marketed as Cosmetics
- CBS News — L'Oreal receives warning letter from FDA over claims on anti-aging products
spotted an error? The club wants to know.
More like this
e.l.f. cast a comedian known for a domestic violence joke — in a beauty ad
Huda Beauty ended its partnership with Huda Mustafa after a slur livestream
e.l.f. killed its e.l.f.ino & Schmarnes campaign after backlash over Matt Rife's casting
Somewhere, someone solved the problem this company failed at. 2nd Opinion →
Comments · 0
Sign in to join the comments.